Trials / Completed
CompletedNCT01001559
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
Combination Deplin® and Antidepressant Therapy Compared to Antidepressant Therapy Alone for an Episode of Major Depression- a Retrospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 242 (actual)
- Sponsor
- Pamlab, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective chart review study to determine if Deplin® 7.5mg-15mg combined with an antidepressant is better than an antidepressant alone in adults with major depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-methylfolate | Subjects must have been on their respective therapies for a minimum of 60 days. L-methylfolate dosing was 7.5 mg or 15 mg daily |
| DRUG | Selective serotonin reuptake inhibitor (SSRI) | Subject must have been on their respective therapy for a minimum of 60 days. Because this was an observational retrospective analysis, dosing of SSRI/SNRI varied on a per patient basis. |
| DRUG | Serotonin and norepinephrine reuptake inhibitor (SNRI) | Subject must have been on their respective therapy for a minimum of 60 days. Because this was an observational retrospective analysis, dosing of SSRI/SNRI varied on a per patient basis. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-12-01
- Completion
- 2011-06-01
- First posted
- 2009-10-26
- Last updated
- 2013-12-19
- Results posted
- 2013-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01001559. Inclusion in this directory is not an endorsement.